Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...
Women with polycystic ovarian syndrome are increasingly turning to blockbuster weight loss drugs from Eli Lilly and Novo ...
Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...
ATLANTA — Tirzepatide appeared highly effective in reducing weight among women with polycystic ovary syndrome (PCOS) and overweight or obesity, real-world data from a retrospective analysis of over ...
The highest risk for second-trimester pregnancy loss and dyslipidemia incidence was seen among patients with hyperandrogenic PCOS. HealthDay News — Four subtypes of polycystic ovary syndrome (PCOS) ...
We are finally getting to grips with the genetics of polycystic ovary syndrome (PCOS), which could open the door to new treatments. PCOS, which is thought to affect up to 1 in 5 women, disrupts how ...
Pfizer is acquiring weight-loss drug developer Metsera in a deal valued at up to $7.3 billion as it tries to catch up in the booming obesity treatment market. A truck driver not paying attention ...
Anyone can develop obstructive sleep apnea (OSA), but there are certain risk factors that can make some people more susceptible to the condition than others. “Obesity, by far, is the main risk factor, ...
If you have an ovarian cyst and suddenly feel a sharp or intense pain in your lower belly, you might wonder if the cyst has ruptured (broken open). A ruptured ovarian cyst can cause a range of ...
TEL AVIV, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results